• 53,998+ CME Conference Registrations Sold
  • 161,994+ Medical Conferences
  • 285 Specialties
  • 11,618 Organizers
  • 158,729 Speakers
  • 159 Countries
  • 4,828 Cities
Home  >  Speakers  >  Jamshid Maddahi
Jamshid Maddahi

Jamshid Maddahi

Director, Professor | Los Angeles, California    United States of America
Cardiology, Cardiovascular Diseases,...More
Spoken at 5 events

Biography :

Dr. Jamshid Maddahi is internationally recognized as a leader and expert in cardiovascular disease research, teaching and patient care. Dr. Maddahi obtained his MD degree with Distinguished Honors in 1975 from Tehran University. He subsequently completed his residency and fellowship training in the United States in Internal Medicine, Cardiovascular Diseases, Nuclear Medicine, and Nuclear cardiology. Dr. Maddahi began his academic and research career in 1977 in the field of Nuclear Cardiology. His pioneering and collaborative research in this field has led to several seminal articles on clinical applications of Nuclear Cardiology. The scope of his research has included development and validation of methods for assessment of myocardial perfusion, detection and risk stratification of patients with suspected or known coronary artery disease, assessment of myocardial viability and cost effectiveness of nuclear imaging in the management of patients. At the present, Nuclear Cardiology has become a standard technique in cardiology. In the US alone, more than 10 million Nuclear Cardiology procedures are done each year. In 1990, Dr. Maddahi became Director of Clinical PET Center at UCLA with the overall goal of extending applications of the new technique of PET scanning into the clinical arena in oncology, cardiology and neurology. Over the ensuing years, the pioneering work of the UCLA team led to ever increasing role of the PET scanning technique in management of patients with cancer and heart disease. In 1998, Dr. Maddahi extended his research interest to the field of Cardiac CT. In 2007.

Dr. Maddahi lead the clinical investigations on the use of a new F-18 labeled PET perfusion agent. This tracer, that is currently in Pahse II clinical trials, has the potential of becoming the dominant tracer for noninvasive assessment of coronary artery disease. Dr. Maddahi became Assistant Professor of Medicine at UCLA in 1981 and is currently Clinical Professor (level 6) of Molecular and Medical Pharmacology (Nuclear Medicine) and Medicine (Cardiology) at David Geffen School of Medicine at UCLA. He is also Director of Biomedical Imaging Institute. The initiative of this institute has been to elevate the quality of cardiac imaging centers in the community. During his academic career, Dr. Maddahi has received several million Dollars of research funding from the National Institute of Health and non governmental sources. He has authored more than 200 original research articles,

For speaker's contact information - Contact us



Interested Topics

Cardiology, Cardiovascular Diseases, Nuclear Medicine, Nuclear Cardiology, Internal Medicine, Patient Care, Coronary Artery Disease, Nuclear Imaging, Clinical PET Center, Oncology, Cardiac CT, Medicine, Medical Pharmacology

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials

The conference session material has yet to be added by the speaker.

Send Message

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.